KRM Ayurveda IPO
Bookbuilding IPO | ₹77.00 Cr | Listing at NSE SME
IPO Open
Mon, Jan 19, 2026
IPO Close
Wed, Jan 21, 2026
Price Band
₹128.00 to ₹135.00
Market Cap (Pre-IPO)
₹287.02 Cr
IPO Details
| IPO Date | Jan 19, 2026 to Jan 21, 2026 |
| Listing Date | Tentative: Jan 27, 2026 |
| Face Value | ₹10.00 per share |
| Price Band | ₹128.00 to ₹135.00 |
| Lot Size | 1000 Shares (Minimum: ₹135,000.00) |
| Sale Type | Fresh Issue |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Issue Size | ₹77.00 Crores |
| Total Shares Offered | 5,740,000 shares |
| Offer For Sale | 5,740,000 shares |
KRM Ayurveda IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
KRM Ayurveda IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹270,000 |
| Retail (Max) | 2 | 2,000 | ₹270,000 |
| S-HNI (Min) | 3 | 3,000 | ₹405,000 |
| S-HNI (Max) | 7 | 7,000 | ₹945,000 |
| B-HNI (Min) | 8 | 8,000 | ₹1,080,000 |
KRM Ayurveda Financial Information (Restated Consolidated)
KRM Ayurveda Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 255% between the financial year ending with March 31, 2025 and March 31, 2024
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 66.79 | 43.91 | 39.48 |
| Total Income | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 12.10 | 3.41 | 7.60 |
| EBITDA | 19.11 | 7.34 | 11.03 |
| NET Worth | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 31.20 | 23.18 | 19.87 |
Amount in ₹ Cr
Key Performance Indicators
As of Monday, March 31, 2025| KPI | Values |
|---|---|
| ROE (Return on Equity) | 67.86% |
| ROCE (Return on Capital Employed) | 43.33% |
| Debt/Equity | 1.31 |
| RoNW (Return on Net Worth) | 67.86% |
| PAT Margin (Profit After Tax Margin) | 15.80% |
| EBITDA Margin | 24.96% |
| Price to Book Value | 0.08 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 7.79 | 5.69 |
| P/E (x) | 17.32 | 23.73 |
| Promoter Holding | 92.15% | 0.00% |
Company Promoters
- Mr. Puneet Dhawan and Mrs. Tanya Dhawan are the promoters of the company.
Company Overview
- Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.
- They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items.
- Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.
- Services & Products:
- Hospitals
- Clinic
- Teleconsultation Services
- KRM Ayurveda Products
- As on August 31, 2025, the company have total of 429 employees operating under various departments.
Company Strengths
- Skilled Ayurvedic physicians and certified therapists ensuring treatment quality.
- Centralized GMP-certified production of Ayurvedic medicines ensuring purity and efficacy.
- Trusted brand with loyal customer base and repeat clientele.
Use of Proceeds
| 1) | Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| 2) | Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| 3) | Human Resources | 5.44 |
| 4) | Repayment/Prepayment of loan | 12.50 |
| 5) | Working Capital Requirement | 18.00 |
| 6) | General Corporate Purposes |
Objectives
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
KRM Ayurveda IPO Peer Comparison
KRM Ayurveda peer comparison with similar listed entities. (As on March 31, 2025)| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| KRM Ayurveda Ltd. | 8.06 | 8.06 | 1,591.72 | 0.00 | 67.86 | 0.00 | - |
| Jeena Sikho Lifecare Limited | 36.50 | 36.50 | 21.96 | 22.02 | 33.00 | 38.29 | Standalone |
| Vaidya Sane Ayurved Laboratories Limited | 4.66 | 4.66 | 56.79 | 65.02 | 9.67 | 5.41 | Standalone |
Quick Info
| Sector | Healthcare - Hospitals and Clinics |
| Exchange | NSE SME |
| Market Cap (Pre-IPO) | ₹287.02 Cr |
| GMP | 0.00 |
Important Dates
| IPO Open | Jan 19, 2026 |
| IPO Close | Jan 21, 2026 |
| Allotment Date | Jan 22, 2026 |
| Credit to Demat | Jan 23, 2026 |
| Listing Date | Tentative: Jan 27, 2026 |
Lead Manager(s)
NEXGEN Financial Solutions Pvt. Ltd.
Registrar
Description
KRM Ayurveda IPO is a book build issue of ₹77.49 crores. The issue is entirely a fresh issue of 0.57 crore shares of ₹77.49 crore.
KRM Ayurveda IPO opens for subscription on Jan 19, 2026 and closes on Jan 21, 2026. The allotment for the KRM Ayurveda IPO is expected to be finalized on Jan 22, 2026. KRM Ayurveda IPO will list on NSE SME with a tentative listing date fixed as Jan 27, 2026.
KRM Ayurveda IPO price band is set at ₹128 to ₹135 per share. The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹2,70,000 (2,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,000 shares), amounting to ₹4,05,000